Precigen Newsroom

Stifel Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsNov 15 08:35 ET

Precigen Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Dow JonesNov 15 07:52 ET

Precigen Analyst Ratings

BenzingaNov 15 07:42 ET

H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsNov 15 06:31 ET

JMP Securities Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsNov 15 00:32 ET

Precigen's Strategic Advancements and FDA Alignment Bolster Buy Rating

TipRanksNov 15 00:29 ET

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Inspire Medical Systems (INSP) and Precigen (PGEN)

TipRanksOct 1 05:09 ET

JMP Securities Maintains Precigen(PGEN.US) With Buy Rating, Cuts Target Price to $7

Moomoo NewsAug 15 20:32 ET

Precigen Price Target Cut to $7.00/Share From $14.00 by JMP Securities

Dow JonesAug 15 11:47 ET

JMP Securities Maintains Market Outperform on Precigen, Lowers Price Target to $7

BenzingaAug 15 11:37 ET

Precigen Analyst Ratings

BenzingaAug 15 08:02 ET

H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Cuts Target Price to $4

Moomoo NewsAug 15 06:31 ET

Buy Rating Affirmed for Precigen Amid Promising PRGN-2012 Clinical Data and Strategic Focus

TipRanksAug 15 06:24 ET

Stifel Nicolaus Sticks to Their Buy Rating for Precigen (PGEN)

TipRanksAug 9 09:22 ET

Buy Rating Backed by Strategic Focus and Solid Clinical Pipeline at Precigen

TipRanksAug 7 00:47 ET

Precigen Analyst Ratings

BenzingaJun 3 12:21 ET

Precigen Analyst Ratings

BenzingaMay 15 06:44 ET

Buy Rating Affirmed for Precigen Amid Promising Clinical Data and Strong Financial Outlook

TipRanksMay 15 06:40 ET

Buy Rating Affirmed for Precigen Amid Promising Clinical Developments and Strategic FDA Alignment

TipRanksMay 15 00:40 ET

Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), Nevro Corp (NVRO) and Precigen (PGEN)

TipRanksMay 8 01:15 ET